O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma. (Q40338018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lea Eisenbach

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

E Tzehoval

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

E Vadai

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

139-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

Glycosylation and the immune system

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

MUC1 and the immunobiology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

MUC1: the polymorphic appearance of a human mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02965.X

Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809564

Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809564

Heterogeneity of mucin gene expression in normal and neoplastic tissues

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809564

The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809564

Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809564

Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells

29 August 2018

1 reference

12 December 2020

Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model

1 reference

12 December 2020

A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy

1 reference

12 December 2020

Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen

1 reference

12 December 2020

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred

1 reference

12 December 2020

High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02965.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367945%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

PMC publication ID

1809564

0 references

1 reference